Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-22-002654

Options or other derivatives

  • Chief Business Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Desmarais William Chief Business Officer 2022-01-18 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…